328 related articles for article (PubMed ID: 2332047)
1. The interaction of amiloride with acetylcholinesterase and butyrylcholinesterase.
Zemach L; Segal D; Shalitin Y
FEBS Lett; 1990 Apr; 263(1):166-8. PubMed ID: 2332047
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of two different cholinesterases by tacrine.
Ahmed M; Rocha JB; Corrêa M; Mazzanti CM; Zanin RF; Morsch AL; Morsch VM; Schetinger MR
Chem Biol Interact; 2006 Aug; 162(2):165-71. PubMed ID: 16860785
[TBL] [Abstract][Full Text] [Related]
3. Time-course of human cholinesterases-catalyzed competing substrate kinetics.
Mukhametgalieva AR; Aglyamova AR; Lushchekina SV; Goličnik M; Masson P
Chem Biol Interact; 2019 Sep; 310():108702. PubMed ID: 31247192
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and in vitro evaluation of novel rhodanine derivatives as potential cholinesterase inhibitors.
Krátký M; Štěpánková Š; Vorčáková K; Vinšová J
Bioorg Chem; 2016 Oct; 68():23-9. PubMed ID: 27428597
[TBL] [Abstract][Full Text] [Related]
5. 'Inverse' substrates for butyrylcholinesterase.
Nozawa M; Tanizawa K; Kanaoka Y
Biochim Biophys Acta; 1980 Feb; 611(2):314-22. PubMed ID: 7357012
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of novel 5-(aroylhydrazinocarbonyl)escitalopram as cholinesterase inhibitors.
Nisa MU; Munawar MA; Iqbal A; Ahmed A; Ashraf M; Gardener QA; Khan MA
Eur J Med Chem; 2017 Sep; 138():396-406. PubMed ID: 28688279
[TBL] [Abstract][Full Text] [Related]
7. Cyclic acyl guanidines bearing carbamate moieties allow potent and dirigible cholinesterase inhibition of either acetyl- or butyrylcholinesterase.
Darras FH; Kling B; Sawatzky E; Heilmann J; Decker M
Bioorg Med Chem; 2014 Sep; 22(17):5020-34. PubMed ID: 25059502
[TBL] [Abstract][Full Text] [Related]
8. Molecular forms of acetylcholinesterase and butyrylcholinesterase in human plasma and cerebrospinal fluid.
Atack JR; Perry EK; Bonham JR; Perry RH
J Neurochem; 1987 Jun; 48(6):1845-50. PubMed ID: 3572402
[TBL] [Abstract][Full Text] [Related]
9. [Substrate and inhibitor specificity of brain cholinesterase of various fly species (Diptera: Anthomyiidae, Muscidae). Enzyme type].
Grigor'eva GM; Krasnova TI; Khovanskikh AE; Lezhneva IP
Zh Evol Biokhim Fiziol; 1997; 33(4-5):431-42. PubMed ID: 9542042
[No Abstract] [Full Text] [Related]
10. Evolution of acetylcholinesterase and butyrylcholinesterase in the vertebrates: an atypical butyrylcholinesterase from the Medaka Oryzias latipes.
Pezzementi L; Nachon F; Chatonnet A
PLoS One; 2011 Feb; 6(2):e17396. PubMed ID: 21364766
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of acetylcholinesterase and butyrylcholinesterase by chlorpyrifos-oxon.
Amitai G; Moorad D; Adani R; Doctor BP
Biochem Pharmacol; 1998 Aug; 56(3):293-9. PubMed ID: 9744565
[TBL] [Abstract][Full Text] [Related]
12. Substrate dependence of amiloride- and soman-induced conformation changes of butyrylcholinesterase as evidenced by high-pressure perturbation.
Cléry C; Heiber-Langer I; Channac L; David L; Balny C; Masson P
Biochim Biophys Acta; 1995 Jul; 1250(1):19-28. PubMed ID: 7612649
[TBL] [Abstract][Full Text] [Related]
13. Cholinesterases inhibition and molecular modeling studies of piperidyl-thienyl and 2-pyrazoline derivatives of chalcones.
Shah MS; Khan SU; Ejaz SA; Afridi S; Rizvi SUF; Najam-Ul-Haq M; Iqbal J
Biochem Biophys Res Commun; 2017 Jan; 482(4):615-624. PubMed ID: 27865835
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of Acetylcholinesterase and Butyrylcholinesterase by a Plant Secondary Metabolite Boldine.
Kostelnik A; Pohanka M
Biomed Res Int; 2018; 2018():9634349. PubMed ID: 29850593
[TBL] [Abstract][Full Text] [Related]
15. Aromatic amino-acid residues at the active and peripheral anionic sites control the binding of E2020 (Aricept) to cholinesterases.
Saxena A; Fedorko JM; Vinayaka CR; Medhekar R; Radić Z; Taylor P; Lockridge O; Doctor BP
Eur J Biochem; 2003 Nov; 270(22):4447-58. PubMed ID: 14622273
[TBL] [Abstract][Full Text] [Related]
16. [Reactivation of phosphorylated cholinesterase immobilized in a gelatin membrane].
Kugusheva LI; Nikol'skaia EB
Ukr Biokhim Zh (1978); 1990; 62(2):93-6. PubMed ID: 2368191
[TBL] [Abstract][Full Text] [Related]
17. Species- and concentration-dependent differences of acetyl- and butyrylcholinesterase sensitivity to physostigmine and neostigmine.
Bitzinger DI; Gruber M; Tümmler S; Michels B; Bundscherer A; Hopf S; Trabold B; Graf BM; Zausig YA
Neuropharmacology; 2016 Oct; 109():1-6. PubMed ID: 26772968
[TBL] [Abstract][Full Text] [Related]
18. Investigation of salicylanilide and 4-chlorophenol-based N-monosubstituted carbamates as potential inhibitors of acetyl- and butyrylcholinesterase.
Krátký M; Štěpánková Š; Vorčáková K; Vinšová J
Bioorg Chem; 2018 Oct; 80():668-673. PubMed ID: 30059892
[TBL] [Abstract][Full Text] [Related]
19. A suitable method to monitor inhibition of cholinesterase activities in tissues as induced by reversible enzyme inhibitors.
Thomsen T; Kewitz H; Pleul O
Enzyme; 1989; 42(4):219-24. PubMed ID: 2698348
[TBL] [Abstract][Full Text] [Related]
20. Tetraalkylammonium derivatives of 6-methyluracil, a new class of cholinesterase inhibitors: characteristics of interaction with cholinesterases from different groups of animals.
Anikienko KA; Bychikhin EA; Kurochkin VK; Reznik VS; Akamsin VD; Galyametdinova IV
Dokl Biochem Biophys; 2001; 376():39-43. PubMed ID: 11712130
[No Abstract] [Full Text] [Related]
[Next] [New Search]
